Design Therapeutics, Inc. (DSGN) Ownership

$3.77

$0.09 (2.45%)
Last update: 01:00 PM EST
Day's range
$3.63
Day's range
$3.84

Design Therapeutics, Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
SR ONE CAPITAL MANAGEMENT, LP 05/13/2025 6.53 M $25.19 M   0.00% 11.50%
LOGOS GLOBAL MANAGEMENT LP 05/15/2025 4.22 M $16.28 M   0.00% 7.43%
BLACKROCK, INC. 05/02/2025 2.48 M $9.57 M   -3.86% 4.37%
FRAZIER LIFE SCIENCES MANAGEMENT, L.P. 05/15/2025 1.95 M $7.54 M   0.00% 3.44%
POINT72 ASSET MANAGEMENT, L.P. 05/15/2025 1.82 M $7.02 M   -2.09% 3.20%
BAKER BROS. ADVISORS LP 05/15/2025 1.74 M $6.73 M   0.00% 3.07%
TANG CAPITAL MANAGEMENT LLC 05/15/2025 1.68 M $6.49 M   13.50% 2.96%
ALMITAS CAPITAL LLC 05/15/2025 1.45 M $5.61 M   9.76% 2.56%
VANGUARD GROUP INC 05/09/2025 1.43 M $5.51 M   -0.23% 2.52%
CITADEL ADVISORS LLC 05/15/2025 963.46 K $3.72 M   0.49% 1.70%
FMR LLC 05/12/2025 948.05 K $3.66 M   -0.40% 1.67%
DRIEHAUS CAPITAL MANAGEMENT LLC 05/15/2025 913.40 K $3.53 M   17.69% 1.61%
KYNAM CAPITAL MANAGEMENT, LP 05/15/2025 904.02 K $3.49 M   100.00% 1.59%
GEODE CAPITAL MANAGEMENT, LLC 05/13/2025 775.50 K $2.99 M   1.82% 1.37%
STATE STREET CORP 05/15/2025 714.07 K $2.76 M   -1.28% 1.26%
WOODLINE PARTNERS LP 05/15/2025 645.69 K $2.49 M   100.00% 1.14%
ACADIAN ASSET MANAGEMENT LLC 05/21/2025 630.95 K $2.43 M   11.16% 1.11%
BIOIMPACT CAPITAL LLC 05/15/2025 562.94 K $2.17 M   0.61% 0.99%
D. E. SHAW & CO., INC. 05/15/2025 395.25 K $1.53 M   -22.85% 0.70%
NORTHERN TRUST CORP 05/13/2025 373.65 K $1.44 M   -3.73% 0.66%
DIMENSIONAL FUND ADVISORS LP 05/13/2025 288.60 K $1.11 M   34.07% 0.51%
GOLDMAN SACHS GROUP INC 06/27/2025 266.02 K $1.03 M   -10.47% 0.47%
RENAISSANCE TECHNOLOGIES LLC 05/14/2025 265.00 K $1.02 M   4.54% 0.47%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 05/09/2025 258.38 K $997.33 K   -2.38% 0.46%
MORGAN STANLEY 05/15/2025 247.88 K $956.81 K   -28.40% 0.44%
05/12/2025 147.23 K $568.30 K   100.00% 0.26%
TWO SIGMA ADVISERS, LP 05/15/2025 146.70 K $566.26 K   -37.28% 0.26%
WELLINGTON MANAGEMENT GROUP LLP 05/13/2025 141.52 K $546.26 K   100.00% 0.25%
TWO SIGMA INVESTMENTS, LP 05/15/2025 128.75 K $496.96 K   -36.87% 0.23%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 05/15/2025 113.80 K $439.27 K   -11.37% 0.20%
BANK OF NEW YORK MELLON CORP 04/29/2025 95.35 K $368.04 K   0.00% 0.17%
MILLENNIUM MANAGEMENT LLC 05/15/2025 87.99 K $339.63 K   100.00% 0.16%
BARCLAYS PLC 05/15/2025 84.01 K $324.00 K   -18.89% 0.15%
GSA CAPITAL PARTNERS LLP 05/08/2025 72.15 K $278.00 K   -39.03% 0.13%
LYNX1 CAPITAL MANAGEMENT LP 05/15/2025 65.95 K $254.58 K   100.00% 0.12%
PALUMBO WEALTH MANAGEMENT LLC 04/22/2025 58.28 K $224.95 K   6.55% 0.10%
PRUDENTIAL FINANCIAL INC 05/13/2025 56.41 K $217.72 K   0.16% 0.10%
BNP PARIBAS ARBITRAGE, SNC 05/14/2025 52.87 K $204.09 K   31.23% 0.09%
RHUMBLINE ADVISERS 05/29/2025 46.37 K $178.98 K   -12.40% 0.08%
AMERICAN CENTURY COMPANIES INC 05/13/2025 44.42 K $171.44 K   13.55% 0.08%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 05/14/2025 43.22 K $166.84 K   15.84% 0.08%
ALLIANCEBERNSTEIN L.P. 05/15/2025 42.09 K $162.47 K   0.00% 0.07%
ASSENAGON ASSET MANAGEMENT S.A. 04/15/2025 36.92 K $142.50 K   -34.80% 0.07%
UBS GROUP AG 05/13/2025 32.82 K $126.68 K   -50.71% 0.06%
AQR CAPITAL MANAGEMENT LLC 05/15/2025 31.74 K $122.52 K   6.31% 0.06%
DEUTSCHE BANK AG\ 05/09/2025 28.13 K $108.58 K   0.12% 0.05%
CI PRIVATE WEALTH, LLC 05/14/2025 26.97 K $104.09 K   0.00% 0.05%
CITIGROUP INC 05/12/2025 22.88 K $88.31 K   -6.52% 0.04%
STRS OHIO 05/28/2025 22.60 K $87.24 K   -30.67% 0.04%
BANK OF AMERICA CORP /DE/ 05/15/2025 22.17 K $85.56 K   -36.96% 0.04%

Design Therapeutics, Inc. institutional Ownership - FAQ's

During the previous two years, 205 institutional investors and hedge funds held shares of Design Therapeutics, Inc.. The most heavily invested institutionals were:

SR ONE CAPITAL MANAGEMENT, LP: 6.53 M

Logos Global Management LP: 4.22 M

BlackRock, Inc.: 2.48 M

Frazier Life Sciences Management, L.P.: 1.95 M

Point72 Asset Management, L.P.: 1.82 M

BAKER BROS. ADVISORS LP: 1.74 M

60.71% of Design Therapeutics, Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 45.00 M shares in the last 24 months. This purchase volume represents approximately $169.63 M in transactions.